Literature DB >> 15064002

Stimulant treatment of adult attention-deficit/hyperactivity disorder.

Thomas Spencer1, Joseph Biederman, Timothy Wilens.   

Abstract

Though only recently recognized as a valid disorder in adults, the clinical picture of adult ADHD is highly reminiscent of childhood ADHD,with continued associated occupational failure and academic deficits. Similarly, many adults with ADHD suffer from antisocial, depressive, and anxiety disorders. Recent work clearly documents that when therapeutic doses of MPH and amphetamine treatment are used in the treatment of adults with ADHD, they can lead to a robust clinical response that is highly consistent with that observed in pediatric studies using equipotent daily doses. As in childhood ADHD, medication remains a key component of treatment for adults with ADHD. More studies are needed to evaluate the efficacy and safety of stimulants over the long-term and their impact on quality of life.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064002     DOI: 10.1016/j.psc.2003.12.002

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  11 in total

1.  Managing ADHD in children, adolescents, and adults with comorbid anxiety in primary care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

2.  Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Xavier Castells; Lídia Blanco-Silvente; Ruth Cunill
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

Review 3.  Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Authors:  Howard Schubiner
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Methylphenidate increases cigarette smoking.

Authors:  Craig R Rush; Stephen T Higgins; Andrea R Vansickel; William W Stoops; Joshua A Lile; Paul E A Glaser
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

5.  Preferences related to attention-deficit/hyperactivity disorder and its treatment.

Authors:  Kate Van Brunt; Louis S Matza; Peter M Classi; Joseph A Johnston
Journal:  Patient Prefer Adherence       Date:  2011-01-17       Impact factor: 2.711

6.  Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL).

Authors:  Louis S Matza; Joseph A Johnston; Douglas E Faries; Karen G Malley; Meryl Brod
Journal:  Qual Life Res       Date:  2007-09-12       Impact factor: 4.147

Review 7.  Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder.

Authors:  J Russell Ramsay
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 8.  Prenatal Alcohol Exposure in Rodents As a Promising Model for the Study of ADHD Molecular Basis.

Authors:  Argelia E Rojas-Mayorquín; Edgar Padilla-Velarde; Daniel Ortuño-Sahagún
Journal:  Front Neurosci       Date:  2016-12-15       Impact factor: 4.677

9.  A pharmacological analysis of stimulant-induced increases in smoking.

Authors:  Andrea R Vansickel; William W Stoops; Paul E A Glaser; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2007-04-20       Impact factor: 4.415

10.  Comparison of Two brands of Methylphenidate (Stimdate(®) vs. Ritalin(®)) in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial.

Authors:  Naser Khodadust; Amir-Hossein Jalali; Masoud Ahmadzad-Asl; Noushin Khademolreza; Elham Shirazi
Journal:  Iran J Psychiatry Behav Sci       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.